Empagliflozin in patients with type 2 diabetes mellitus and chronic obstructive pulmonary disease-Reference-Cited by-同舟云学术

Empagliflozin in patients with type 2 diabetes mellitus and chronic obstructive pulmonary disease

Published:2022-04 Issue: Volume:186 Page:109837
ISSN:0168-8227
Container-title:Diabetes Research and Clinical Practice
language:en
Short-container-title:Diabetes Research and Clinical Practice

Author:

Anker Stefan D.,Sander Leif-Erik,Fitchett David H.,Zinman Bernard,Pernille Ofstad Anne,Wanner Christoph,Vedin Ola,Lauer Sabine,Verma Subodh,Yaggi Henry K.,Inzucchi Silvio E.

Funder

Boehringer Ingelheim

Publisher

Elsevier BV

Subject

Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference34 articles.

1. Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD;Mannino;Eur Respir J,2008

2. Ho T-W, Huang C-T, Ruan S-Y, Tsai Y-J, Lai F, Yu C-J. Diabetes mellitus in patients with chronic obstructive pulmonary disease–The impact on mortality. PLoS One 2017;12:e0175794.

3. Patients diagnosed with diabetes are at increased risk for asthma, chronic obstructive pulmonary disease, pulmonary fibrosis, and pneumonia but not lung cancer;Ehrlich;Diabetes Care,2010

4. Heart failure and chronic obstructive pulmonary disease: diagnostic pitfalls and epidemiology;Hawkins;Eur J Heart Fail,2009

5. Comorbidities and chronic obstructive pulmonary disease: prevalence, influence on outcomes, and management;Putcha;Semin Respir Crit Care Med,2015

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sodium–Glucose Cotransporter-2 Inhibitor, Empagliflozin, Suppresses the Inflammatory Immune Response to Influenza Infection;ImmunoHorizons;2023-12-01

2. Respiratory Outcomes of Insulin Use in Patients with COPD: A Nationwide Population-Based Cohort Study;Pharmaceuticals;2023-04-24

3. Integrating RNA-seq and scRNA-seq to explore the mechanism of macrophage ferroptosis associated with COPD;Frontiers in Pharmacology;2023-03-10

4. The Efficacy and Safety of Budesonide/Glycopyrronium/Formoterol in the Treatment of COPD in the Elderly;Contrast Media & Molecular Imaging;2022-08-17

5. Meta-Analysis Assessing the Cardiovascular Efficacy of Sodium-Glucose Co-Transporter-2 Inhibitors in Patients With Chronic Obstructive Pulmonary Disease;The American Journal of Cardiology;2022-07